FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4319015978> ?p ?o ?g. }

• W4319015978 endingPage "931" @default.
• W4319015978 startingPage "931" @default.
• W4319015978 abstract "Sorafenib is the first approved systemic targeting agent for advanced HCC; however, when used alone, drug resistance can result in considerably reduced efficacy. Here, we demonstrate that niclosamide, an antihelminthic agent approved by the US Food and Drug Administration, can be repurposed to increase sorafenib sensitivity in sorafenib-resistant HCC cells. We generated sorafenib-resistant HCC cell lines (HepG2215_R and Hep3B_R) with elevated IGF-1R levels and strong properties in terms of stemness and epithelial–mesenchymal transition. Niclosamide was found to increase sorafenib sensitivity effectively in both cell lines and their organoids. The underlying mechanism involves the modulation of cancer stemness, IGF-1R/p-IGF1R/OCT4, and metabolic changes. The combination of sorafenib and niclosamide, but not linsitinib, effectively suppressed the IGF-1R/OCT4 expressions, yielded a synergistic combination index (CI), and attenuated stemness-related properties such as secondary tumor sphere formation and cell migration in sorafenib-resistant HCC cells. Notably, niclosamide significantly suppressed the sorafenib-induced IGF-1R phosphorylation prompted by IGF-1 treatment. Niclosamide effectively downregulated the sorafenib-induced gene expression associated with glycolysis (GLUT1, HK2, LDHA, and PEPCK), stemness (OCT4), and drug resistance (ABCG2) and enhanced the ability of sorafenib to reduce the mitochondrial membrane potential in vitro. The synergistic effect of a combination of niclosamide and sorafenib in vivo was further demonstrated by the decreased tumor size and tumor volume resulting from apoptosis regulation. Our results suggest that niclosamide can enhance sorafenib sensitivity in sorafenib-resistant HCC cells through IGF-1R/stemness regulation and metabolic changes. Our findings highlight a practical clinical strategy for enhancing sorafenib sensitivity in HCC." @default.
• W4319015978 created "2023-02-03" @default.
• W4319015978 creator A5000882343 @default.
• W4319015978 creator A5021453806 @default.
• W4319015978 creator A5027192230 @default.
• W4319015978 creator A5029270880 @default.
• W4319015978 creator A5031957353 @default.
• W4319015978 creator A5068206783 @default.
• W4319015978 creator A5071953824 @default.
• W4319015978 creator A5084321349 @default.
• W4319015978 date "2023-02-01" @default.
• W4319015978 modified "2023-09-27" @default.
• W4319015978 title "Niclosamide Revitalizes Sorafenib through Insulin-like Growth Factor 1 Receptor (IGF-1R)/Stemness and Metabolic Changes in Hepatocellular Carcinoma" @default.
• W4319015978 cites W1969489445 @default.
• W4319015978 cites W1971490477 @default.
• W4319015978 cites W1971837077 @default.
• W4319015978 cites W1976544205 @default.
• W4319015978 cites W1980324695 @default.
• W4319015978 cites W1985819704 @default.
• W4319015978 cites W1994193851 @default.
• W4319015978 cites W2024266347 @default.
• W4319015978 cites W2024436494 @default.
• W4319015978 cites W2098760354 @default.
• W4319015978 cites W2110345152 @default.
• W4319015978 cites W2112034262 @default.
• W4319015978 cites W2112796039 @default.
• W4319015978 cites W2115991409 @default.
• W4319015978 cites W2137052325 @default.
• W4319015978 cites W2138424758 @default.
• W4319015978 cites W2138544728 @default.
• W4319015978 cites W2146447952 @default.
• W4319015978 cites W2152211177 @default.
• W4319015978 cites W2160855995 @default.
• W4319015978 cites W2480131545 @default.
• W4319015978 cites W2514939467 @default.
• W4319015978 cites W2556093773 @default.
• W4319015978 cites W2560499218 @default.
• W4319015978 cites W2569465708 @default.
• W4319015978 cites W2591862054 @default.
• W4319015978 cites W2598230851 @default.
• W4319015978 cites W2605112455 @default.
• W4319015978 cites W2611921638 @default.
• W4319015978 cites W2767110894 @default.
• W4319015978 cites W2787358630 @default.
• W4319015978 cites W2793431601 @default.
• W4319015978 cites W2799303607 @default.
• W4319015978 cites W2800251141 @default.
• W4319015978 cites W2800547872 @default.
• W4319015978 cites W2809889937 @default.
• W4319015978 cites W2883781711 @default.
• W4319015978 cites W2891441613 @default.
• W4319015978 cites W2897214576 @default.
• W4319015978 cites W2898459923 @default.
• W4319015978 cites W2918149478 @default.
• W4319015978 cites W2972910291 @default.
• W4319015978 cites W2980069459 @default.
• W4319015978 cites W2991450463 @default.
• W4319015978 cites W2997193190 @default.
• W4319015978 cites W2999483628 @default.
• W4319015978 cites W3023195808 @default.
• W4319015978 cites W3025022288 @default.
• W4319015978 cites W3035408975 @default.
• W4319015978 cites W3037793360 @default.
• W4319015978 cites W3120086334 @default.
• W4319015978 cites W3128646645 @default.
• W4319015978 cites W3131916754 @default.
• W4319015978 cites W3170434929 @default.
• W4319015978 cites W3184051666 @default.
• W4319015978 cites W3213277274 @default.
• W4319015978 cites W4205565447 @default.
• W4319015978 cites W4220891427 @default.
• W4319015978 cites W4243903519 @default.
• W4319015978 doi "https://doi.org/10.3390/cancers15030931" @default.
• W4319015978 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36765890" @default.
• W4319015978 hasPublicationYear "2023" @default.
• W4319015978 type Work @default.
• W4319015978 citedByCount "1" @default.
• W4319015978 countsByYear W43190159782023 @default.
• W4319015978 crossrefType "journal-article" @default.
• W4319015978 hasAuthorship W4319015978A5000882343 @default.
• W4319015978 hasAuthorship W4319015978A5021453806 @default.
• W4319015978 hasAuthorship W4319015978A5027192230 @default.
• W4319015978 hasAuthorship W4319015978A5029270880 @default.
• W4319015978 hasAuthorship W4319015978A5031957353 @default.
• W4319015978 hasAuthorship W4319015978A5068206783 @default.
• W4319015978 hasAuthorship W4319015978A5071953824 @default.
• W4319015978 hasAuthorship W4319015978A5084321349 @default.
• W4319015978 hasBestOaLocation W43190159781 @default.
• W4319015978 hasConcept C121608353 @default.
• W4319015978 hasConcept C126322002 @default.
• W4319015978 hasConcept C18903297 @default.
• W4319015978 hasConcept C2776306103 @default.
• W4319015978 hasConcept C2778019345 @default.
• W4319015978 hasConcept C2778695046 @default.
• W4319015978 hasConcept C2779013556 @default.
• W4319015978 hasConcept C502942594 @default.
• W4319015978 hasConcept C71924100 @default.
• W4319015978 hasConcept C76419328 @default.

• next